Stryker has entered into a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, a family-owned investment firm specializing in the neuro-musculoskeletal sector. The sale will establish a new company, VB Spine, which will focus on advancing spinal implant solutions. Following the transaction, VB Spine will have exclusive access to Stryker’s Mako Spine and Copilot technologies for use with its spinal implants. Both companies anticipate that this deal will drive growth, improve patient care, and strengthen their respective market strategies. The transaction is expected to close in the first half of 2025, pending regulatory approvals and other customary conditions.
The agreement also includes a binding offer for Viscogliosi Brothers to acquire Stryker’s spinal implants business in France, subject to employee consultations. The sale of additional international operations is under consideration, depending on legal and regulatory requirements. Until the deal is finalized, both entities will continue operating independently. Barings is supporting the transaction as an investor and financial partner to the Viscogliosi Brothers. Established in 1999, Viscogliosi Brothers focuses on driving advancements in the neuro-musculoskeletal industry, while Barings is a global asset management firm offering financial solutions to businesses worldwide.
